ConductScience.org, home

Gene · 10019

Papers2,160

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

101 to 120 of 2,160

Download this page as JSON
TitleJournalYearPMIDFound bySource
Rare SH2B3 coding variants in lupus patients impair B cell tolerance and predispose to autoimmunity.J Exp Med202438417019PubTator, text miningPubMed
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.Blood Adv202438386975PubTator, text miningPubMed
[Clinical and prognostic characteristics of pediatric acute myeloid leukemia with myelodysplasia-related changes under different diagnostic criteria].Zhonghua Er Ke Za Zhi202438378287PubTator, text miningPubMed
LNK/SH2B3 loss of function increases susceptibility to murine and human atrial fibrillation.Cardiovasc Res202438377486PubTator, text miningPubMed
Genotypes predisposing for celiac disease and autoimmune diabetes and risk of infections in early childhood.J Pediatr Gastroenterol Nutr202438374560PubTator, text miningPubMed
The circadian clock and thermal regulation in plants: novel insights into the role of positive circadian clock regulators in temperature responses.J Exp Bot202438373194PubTator, text miningPubMed
Protein-protein interaction network-based integration of GWAS and functional data for blood pressure regulation analysis.Hum Genomics202438326862PubTator, text miningPubMed
Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications.Nat Commun202438291025PubTator, text miningPubMed
Case Report: A rare form of congenital erythrocytosis due to SLC30A10 biallelic variants-differential diagnosis and recommendation for biochemical and genetic screening.Front Pediatr202438283630PubTator, text miningPubMed
14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer.Cell Commun Signal202438279176PubTator, text miningPubMed
Novel Insights in Venous Thromboembolism Risk Assessment Methods in Ambulatory Cancer Patients: From the Guidelines to Clinical Practice.Cancers (Basel)202438275899PubTator, text miningPubMed
Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis.Int J Mol Sci202438256115PubTator, text miningPubMed
Myeloproliferative Neoplasms: Diseases Mediated by Chronic Activation of Signal Transducer and Activator of Transcription (STAT) Proteins.Cancers (Basel)202438254802PubTator, text miningPubMed
Novel insights into the complex interplay of immune dysregulation and inflammatory biomarkers in preeclampsia and fetal growth restriction: A two-step Mendelian randomization analysis.J Transl Autoimmun202438225945PubTator, text miningPubMed
Strategies to overcome low MHC-I expression in paediatric and adult tumours.Immunother Adv202438223409PubTator, text miningPubMed
Development and validation of a model for the early prediction of progression from essential thrombocythemia to post-essential thrombocythemia myelofibrosis: a multicentre retrospective study.EClinicalMedicine202438188688PubTator, text miningPubMed
Interferon gamma in the pathogenesis of hypertension - recent insights.Curr Opin Nephrol Hypertens202438164939PubTator, text miningPubMed
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.Haematologica202438152053PubTator, text miningPubMed
STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient.Cancer Gene Ther202438135698PubTator, text miningPubMed
The genetics of Graves' disease.Rev Endocr Metab Disord202438108994PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10019/papers?page=6